NYSE$HNGE
Hinge Health Inc · Q2 2025 earnings
Q2 2025 earnings · · Investor relations
Briefing
Hinge Health reported Q2 2025, revenue of $142M, net loss of $45M, diluted EPS of $-0.18.
For Q2 2025, Hinge Health reported revenue of $142M, a net loss of $45M, diluted EPS was $-0.18. Management discusses operating trends, capital, and sector risks in the quarterly filing.
- Revenue $142M.
- Net loss $45M.
- Diluted EPS $-0.18.
- Hinge Health MD&A highlights liquidity, capital, and core trends.
- Segment and macro factors shape year-over-year comparisons.
Headline financials
Revenue & EPS history
Hinge Health, Inc. · Revenue · Quarterly
$139M
Forward guidance
Management discusses operational priorities, capital allocation, and sector risks in the quarterly filing.
Tailwinds
- Execution on core operating metrics cited in MD&A.
- Balance sheet liquidity and covenant headroom.
- Strategic investments supporting long-term growth.
Headwinds
- Macro demand and input-cost volatility.
- Regulatory or competitive pressures in the sector.
- One-time items affecting GAAP comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports
+7.3%
Avg return
Earnings day
+9.1%
Avg return
5 days after
+15.0%
Avg return
30 days after
75%
3 / 4 earnings
Positive
+17.3%
Q4 2025
Best reaction
-1.6%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.4% | +15.3% | +29.3% | |
| Q4 2025 | +17.3% | +17.8% | +36.2% | |
| Q3 2025 | -1.6% | +2.8% | -2.5% | |
| Q2 2025 | +11.3% | +0.3% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro